Bevacizumab in the Treatment of Non-Small-Cell Lung Cancer

Oncogene - United Kingdom
doi 10.1038/sj.onc.1210366
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Bevacizumab in Small Cell Lung Cancer

Annals of Translational Medicine
Medicine
2017English

Bevacizumab for the Treatment of Non-Small Cell Lung Cancer Patients With Synchronous Brain Metastases

Scientific Reports
Multidisciplinary
2019English

Bevacizumab in the Treatment of Nonsquamous Non-Small Cell Lung Cancer: Clinical Trial Evidence and Experience

Therapeutic Advances in Respiratory Disease
PulmonaryRespiratory MedicinePharmacology
2016English

Innovations in the Treatment of Non-Small Cell Lung Cancer

English

Individualization of Treatment in Non-Small Cell Lung Cancer

F1000 Medicine Reports
2009English

Afatinib Treatment in Advanced Non-Small Cell Lung Cancer

Lung Cancer: Targets and Therapy
Oncology
2011English

Bevacizumab Combination Chemotherapy in Clinical Practice for Advanced Non-Squamous Non-Small Cell Lung Cancer

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2013English

On the Pharmacogenetics of Non-Small Cell Lung Cancer Treatment

Expert Opinion on Drug Metabolism and Toxicology
MedicineToxicologyPharmacology
2016English

Gefitinib for the Treatment of Non-Small-Cell Lung Cancer

Expert Opinion on Pharmacotherapy
MedicinePharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy